Clinical Trials

50 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07479407 2026-03-18

PREHAB

74 enrolled

Carcinoma, Non-Small-Cell Lung, Postoperative Complications

NCT07001995 2026-03-16

Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression

30 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07472478 2026-03-16

GIVEN

32 enrolled

Phase 1/2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07472647 2026-03-16

SYS6090 Combination Therapy in Advanced Lung Cancer

596 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07322341 2026-03-13

SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer

32 enrolled

Phase 4 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07469488 2026-03-13

AmiCARE

122 enrolled

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Venous Thromboembolism

NCT07327736 2026-03-12

Anesthesia Comparison in Early-stage Small NSCLC: A Multicenter RCT

410 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07452224 2026-03-12

ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer

80 enrolled

Phase 1/2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07435038 2026-03-11

Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

120 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT07463677 2026-03-11

Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer

55 enrolled

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07464327 2026-03-11

A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations

450 enrolled

Phase 1 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07461727 2026-03-10

An Open-Label, Single-Arm, Dose-Escalation Phase I Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of EDB-102 in Patients With EGFR L858R-Mutant, Third-Generation TKI-Resistant Advanced Non-Small Cell Lung Cancer With Liver Metastases

15 enrolled

Phase 1/2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07453394 2026-03-06

QLS5132 Combination Therapy in Advanced Solid Tumors

626 enrolled

GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT07442292 2026-03-05

PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor

Not yet recruiting

40 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma

NCT06634056 2026-03-04

P4-PACIFIC

150 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06813664 2026-03-04

CURB-TKI

60 enrolled

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07442565 2026-03-04

SYNSTAR03

506 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07450183 2026-03-04

Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

33 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07444437 2026-03-03

LM103 in Phase IIa Clinical Trial for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07432802 2026-02-27

STRADOS

182 enrolled